Antimicrobial Agents and Chemotherapy · 2019 · 60 citations · 22 references
Life SciencesInfectious DiseasesMicrobiologyBacteriologyMedical MicrobiologyMusculoskeletal InfectionAntibacterial PharmacotherapyAntibacterial TherapyAntimicrobial TherapyBacterial InfectionsBone InfectionsMicrobiology Of Musculoskeletal InfectionBacterial Biofilm ControlBacterial Biofilm EffectsBacterial Infection TreatmentBacteriophage TherapyBacteriophagesBiofilm-active Antibiotic TherapyBone Infection BiofilmsBone Infection Therapy
Staphylococcus aureus is responsible for difficult-to-treat bone and joint infections (BJIs). This is related to its ability to form biofilm and to be internalized and persist inside osteoblasts. Recently, bacteriophage therapy has emerged as a promising option to improve treatment of such infections, but data on its activity against the specific bacterial lifestyles presented above remain scarce. We evaluated the activity of a combination of three bacteriophages, recently used for compassionate treatment in France, against S. aureus HG001 in a model of staphylococcal biofilm and a model of osteoblasts infection, alone or in association with vancomycin or rifampin.
22